CheckEye
PrivateLast Round
Grant
May 1, 2025
Total Funding Raised
$125,000
Company Overview
CheckEye operates in Healthcare & Life Sciences and is based in Kyiv. Its latest recorded funding round was a Grant round in May 2025.
CheckEye is a healthtech company that provides an AI-driven platform for the early detection and screening of chronic diseases, such as diabetic retinopathy, using retinal imaging.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Telemedicine, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CheckEye Comparables
Compare CheckEye with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eyenuk | 88% | |
| AEYE Health | 84% | |
| RetinaLyze System A/S | 83% |
For institutional investors. Book with your work email.
CheckEye Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 1, 2025 | ||||
| Angel | Feb 1, 2025 | ||||
| Grant | Jun 20, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CheckEye Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ukraine-Moldova American Enterprise Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors increased 102% MoM, reaching 2.4K.
- Feb 22, 2026
Grew 23% QoQ from 13 to 16 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesNov 2, 2026
Checkeye Limited offers an AI-powered cloud platform that analyzes retinal photographs to identify signs of diabetic retinopathy and other chronic vascular conditions, with more than 20,000 examinations performed at 20 healthcare facilities in Ukraine as of Oct 30th '26.
- recognized_asOct 30, 2026
Ukrainian startup Checkeye Limited takes second place in an international medical innovation competition on Oct 29th '26.
- attends_eventOct 29, 2026
Checkeye Limited attends the Healthy Longevity Global Competition in District of Columbia on Oct 29th '26, takes second place, and receives a $175,000 award.
- receives_financingOct 29, 2026
On Oct 20th '26, Checkeye Limited receives a $175K award from the U.S. National Academy of Medicine in United States for its AI-powered retinal screening technology that supports early detection of chronic diseases.
- is_developingOct 29, 2026
On Oct 29th '26, Ukrainian medical startup Checkeye Limited is developing an artificial intelligence system that analyzes retinal images to detect chronic diseases, currently focusing on diabetic retinopathy and vascular diseases.
For institutional investors. Book with your work email.
CheckEye Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CheckEye's valuation, stock price, and market status.
Is CheckEye a public or private company?
CheckEye is a private company.
What is the current stock price of CheckEye?
CheckEye is a private company, so its shares have no public market price. Caplight tracks CheckEye's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CheckEye worth (valuation)?
Valuation information for CheckEye is not publicly available.
Can I buy CheckEye stock?
CheckEye shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CheckEye's last funding round?
CheckEye's most recent funding round was Grant on May 1, 2025.
Who are the main investors in CheckEye?
Key investors in CheckEye include Ukraine-Moldova American Enterprise Fund.
Will CheckEye IPO soon?
No public IPO plans have been announced for CheckEye.
How can I track CheckEye secondary market activity?
Caplight tracks bids, offers, and trades in CheckEye's shares on secondary markets.